branchenspezifische Dividenden MindMaze Therapeutics Holding SA
Aktien
A3EFB5
CH1251125998
RLF
Biotechnologie
|
Verzögert
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1.080 CHF | -0.37% |
|
-4.77% | -43.26% |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 77.82x | - | -8.93x | 215 Mio. | ||
| 0.95% | 1.08% | 36.1x | 3.7x | 5.24x | 17.58x | 25.75x | 47.17 Mrd. | ||
| -.--% | -.--% | 106.93x | 9.65x | 6.85x | 68.55x | 99.91x | 38.6 Mrd. | ||
| 0.31% | 0.31% | 61.08x | 2.91x | 12.47x | 34.89x | 44.8x | 34.53 Mrd. | ||
| -.--% | -.--% | 27.24x | 5.17x | 2.84x | 12.17x | 19.73x | 32.68 Mrd. | ||
| -.--% | -.--% | -17.32x | 11.78x | 4944x | -16.15x | -15.95x | 18.7 Mrd. | ||
| -.--% | -.--% | 35.83x | 35.77x | 5.79x | 26.3x | 27.57x | 14.94 Mrd. | ||
| 0.94% | 1.11% | 25.82x | 2.3x | 2.11x | 9.46x | 14.63x | 14.13 Mrd. | ||
| -.--% | -.--% | -37.46x | 49.88x | 14.25x | -40.66x | -35.7x | 13.73 Mrd. | ||
| -.--% | -.--% | -53.33x | 6218.32x | 15.65x | -100.67x | -82.74x | 13.63 Mrd. | ||
| -.--% | -.--% | 22.97x | 1.26x | 1.84x | 9.38x | 10.44x | 11.8 Mrd. | ||
| 0.4% | 0.23% | 25.89x | 2.89x | 5.24x | 14.25x | 17.67x | 10.46 Mrd. | ||
| 0.49% | 0.49% | 52.11x | 4.71x | 8.3x | 23.23x | 25.57x | 10.24 Mrd. | ||
| -.--% | -.--% | -38.53x | 19.87x | 8.5x | 18561.16x | -178.78x | 10.16 Mrd. | ||
| Durchschnitt | 0.24% | 0.25% | 19.03x | 489.86x | 365.06x | 1’432.27x | -2.57x | 19.36 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 0.29% | 0.31% | 32.68x | 322.51x | 347.92x | 710.86x | 17.41x |
- Börse
- Aktien
- A3EFB5 Aktie
- Sektor MindMaze Therapeutics Holding SA
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















